Viral vector demand still exceeds capacity, according to analysts who say biopharma firms and CDMOs need new facilities and more efficient production processes. Industry concerns about vector supplies ...
MALVERN, Pa.--(BUSINESS WIRE)--Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing ...
Over the evaluation period from 2023 to 2033, the global viral vector development market is predicted to grow at a remarkable CAGR of 18.7%. By the end of 2023, the global market is anticipated to be ...
The VDL is currently restructuring and not providing services at this time. For all request of viral vectors, please visit the Gene Vector Core Website or send an email to [email protected]. Since ...
The Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, reflecting a robust CAGR of 18.7% over ...
The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA. Thermo Fisher Scientific announced on May 11, 2020 that it is building a new commercial manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback